Other studies have reported that PODXL inhibition greatly increased cell death in breast cancer and in lung cancer [19,25], but we found that PODXL knockdown did not significantly change cell viability with IR or not, suggesting that PODXL is markedly associated with cell movement rather than cell growth in CRC (Figure S2). The gene discussed is PODXL; the disease is breast carcinoma.